308 related articles for article (PubMed ID: 31433750)
1. Blood Brain Barrier Permeability Prediction Using Machine Learning Techniques: An Update.
Saxena D; Sharma A; Siddiqui MH; Kumar R
Curr Pharm Biotechnol; 2019; 20(14):1163-1171. PubMed ID: 31433750
[TBL] [Abstract][Full Text] [Related]
2. A Human Immortalized Cell-Based Blood-Brain Barrier Triculture Model: Development and Characterization as a Promising Tool for Drug-Brain Permeability Studies.
Ito R; Umehara K; Suzuki S; Kitamura K; Nunoya KI; Yamaura Y; Imawaka H; Izumi S; Wakayama N; Komori T; Anzai N; Akita H; Furihata T
Mol Pharm; 2019 Nov; 16(11):4461-4471. PubMed ID: 31573814
[TBL] [Abstract][Full Text] [Related]
3. Porcine brain microvessel endothelial cells as an in vitro model to predict in vivo blood-brain barrier permeability.
Zhang Y; Li CS; Ye Y; Johnson K; Poe J; Johnson S; Bobrowski W; Garrido R; Madhu C
Drug Metab Dispos; 2006 Nov; 34(11):1935-43. PubMed ID: 16896068
[TBL] [Abstract][Full Text] [Related]
4. In vitro porcine blood-brain barrier model for permeability studies: pCEL-X software pKa(FLUX) method for aqueous boundary layer correction and detailed data analysis.
Yusof SR; Avdeef A; Abbott NJ
Eur J Pharm Sci; 2014 Dec; 65():98-111. PubMed ID: 25239510
[TBL] [Abstract][Full Text] [Related]
5. Predict drug permeability to blood-brain-barrier from clinical phenotypes: drug side effects and drug indications.
Gao Z; Chen Y; Cai X; Xu R
Bioinformatics; 2017 Mar; 33(6):901-908. PubMed ID: 27993785
[TBL] [Abstract][Full Text] [Related]
6. Application of an in Vitro Blood-Brain Barrier Model in the Selection of Experimental Drug Candidates for the Treatment of Huntington's Disease.
Di Marco A; Gonzalez Paz O; Fini I; Vignone D; Cellucci A; Battista MR; Auciello G; Orsatti L; Zini M; Monteagudo E; Khetarpal V; Rose M; Dominguez C; Herbst T; Toledo-Sherman L; Summa V; Muñoz-Sanjuán I
Mol Pharm; 2019 May; 16(5):2069-2082. PubMed ID: 30916978
[TBL] [Abstract][Full Text] [Related]
7. In-vitro blood-brain barrier models for drug screening and permeation studies: an overview.
Bagchi S; Chhibber T; Lahooti B; Verma A; Borse V; Jayant RD
Drug Des Devel Ther; 2019; 13():3591-3605. PubMed ID: 31695329
[TBL] [Abstract][Full Text] [Related]
8. A method to predict different mechanisms for blood-brain barrier permeability of CNS activity compounds in Chinese herbs using support vector machine.
Jiang L; Chen J; He Y; Zhang Y; Li G
J Bioinform Comput Biol; 2016 Feb; 14(1):1650005. PubMed ID: 26632324
[TBL] [Abstract][Full Text] [Related]
9. Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood-brain barrier penetration models.
Hellinger E; Veszelka S; Tóth AE; Walter F; Kittel A; Bakk ML; Tihanyi K; Háda V; Nakagawa S; Duy TD; Niwa M; Deli MA; Vastag M
Eur J Pharm Biopharm; 2012 Oct; 82(2):340-51. PubMed ID: 22906709
[TBL] [Abstract][Full Text] [Related]
10. In vitro blood-brain barrier models using brain capillary endothelial cells isolated from neonatal and adult rats retain age-related barrier properties.
Takata F; Dohgu S; Yamauchi A; Matsumoto J; Machida T; Fujishita K; Shibata K; Shinozaki Y; Sato K; Kataoka Y; Koizumi S
PLoS One; 2013; 8(1):e55166. PubMed ID: 23383092
[TBL] [Abstract][Full Text] [Related]
11. LightBBB: computational prediction model of blood-brain-barrier penetration based on LightGBM.
Shaker B; Yu MS; Song JS; Ahn S; Ryu JY; Oh KS; Na D
Bioinformatics; 2021 May; 37(8):1135-1139. PubMed ID: 33112379
[TBL] [Abstract][Full Text] [Related]
12. A Recurrent Neural Network model to predict blood-brain barrier permeability.
Alsenan S; Al-Turaiki I; Hafez A
Comput Biol Chem; 2020 Dec; 89():107377. PubMed ID: 33010784
[TBL] [Abstract][Full Text] [Related]
13. Mimicking brain tissue binding in an in vitro model of the blood-brain barrier illustrates differences between in vitro and in vivo methods for assessing the rate of brain penetration.
Heymans M; Sevin E; Gosselet F; Lundquist S; Culot M
Eur J Pharm Biopharm; 2018 Jun; 127():453-461. PubMed ID: 29602020
[TBL] [Abstract][Full Text] [Related]
14. In Silico Prediction of Blood-Brain Barrier Permeability of Compounds by Machine Learning and Resampling Methods.
Wang Z; Yang H; Wu Z; Wang T; Li W; Tang Y; Liu G
ChemMedChem; 2018 Oct; 13(20):2189-2201. PubMed ID: 30110511
[TBL] [Abstract][Full Text] [Related]
15. Hurdles with using in vitro models to predict human blood-brain barrier drug permeability: a special focus on transporters and metabolizing enzymes.
Shawahna R; Decleves X; Scherrmann JM
Curr Drug Metab; 2013 Jan; 14(1):120-36. PubMed ID: 23215812
[TBL] [Abstract][Full Text] [Related]
16. In vitro models of the blood-brain barrier for the study of drug delivery to the brain.
Wilhelm I; Krizbai IA
Mol Pharm; 2014 Jul; 11(7):1949-63. PubMed ID: 24641309
[TBL] [Abstract][Full Text] [Related]
17. Improved Prediction of Blood-Brain Barrier Permeability Through Machine Learning with Combined Use of Molecular Property-Based Descriptors and Fingerprints.
Yuan Y; Zheng F; Zhan CG
AAPS J; 2018 Mar; 20(3):54. PubMed ID: 29564576
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.
Mensch J; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
Eur J Pharm Biopharm; 2010 Mar; 74(3):495-502. PubMed ID: 20067834
[TBL] [Abstract][Full Text] [Related]
19. Microfluidic blood-brain barrier model provides in vivo-like barrier properties for drug permeability screening.
Wang YI; Abaci HE; Shuler ML
Biotechnol Bioeng; 2017 Jan; 114(1):184-194. PubMed ID: 27399645
[TBL] [Abstract][Full Text] [Related]
20. [Computer modeling of blood brain barrier permeability of physiologically active compounds].
Raevskiĭ OA; Solodova SL; Lagunin AA; Poroĭkov VV
Biomed Khim; 2014; 60(2):161-81. PubMed ID: 24837308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
